Results 111 to 120 of about 5,422,838 (209)

Invasive Meningococcal Disease on the Workplaces: a systematic review.

open access: yesActa bio-medica : Atenei Parmensis, 2017
Background and aims of the work: Invasive Meningococcal Disease (IMD) represents a global health threat, and occupational settings have the potential to contribute to its spreading. Therefore, here we present the available evidences on the epidemiology of IMD on the workplaces.The following key words were used to explore PubMed: Neisseria meningitidis,
Riccò, Matteo   +3 more
openaire   +3 more sources

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is characterized by high mortality and morbidity. While IMD incidence peaks in both infants and adolescents/young adults, carriage rates are often highest in the latter age groups ...
Cynthia Burman   +5 more
doaj   +1 more source

Invasive meningococcal disease in children in Ireland, 2001-2011.

open access: yes, 2016
In 1999, invasive meningococcal disease was hyperendemic in Ireland at 14.75/100 000 population, with 60% group B and 30% group C diseases. National sepsis guidelines and meningococcal C vaccines were introduced in 2000.
Ó Maoldomhnaigh, Cilian   +4 more
core   +1 more source

Meningococcal Disease [PDF]

open access: yes
Meningococcal disease is a rare, but very serious bacterial illness. It can cause long-term problems, like loss of limbs or brain damage, and be deadly.

core   +2 more sources

Invasive meningococcal disease: Which vaccines protect against it?

open access: yes, 2018
Invasive meningococcal disease is a rare, but life-threatening cause of meningitis and septicaemia. Karen Ford describes the disease and causative bacteria, and provides a summary of the vaccines used to prevent it Invasive meningococcal disease is a ...
Karen J Ford
core   +1 more source

UK guidelines and testing for invasive meningococcal disease [PDF]

open access: yesThe Lancet Infectious Diseases, 2021
Stephen A, Clark   +4 more
openaire   +2 more sources

Rapid rebound of invasive meningococcal disease in France at the end of 2022

open access: yes, 2023
International audienceIntroductionInvasive meningococcal disease (IMD) cases declined upon the implementation of non-pharmaceutical measures to control the COVID-19 pandemic (1).
Deghmane, Ala-Eddine   +2 more
core   +1 more source

Invasive Meningococcal Disease. Cuba, 1983- 2006

open access: yesVacciMonitor, 2010
Invasive Meningococcal Disease (IMD) is a worldwide health problem. In Cuba, vaccination against meningococcal B-C has been carried out since 1989. The study aimed at describing the epidemiology of IMD in Cuba from 1983 to 2006 and at contributing to the
Antonio E. Pérez   +2 more
doaj  

Meningoccocal meningitis complicated with subdural effusion: a report of two infant cases

open access: yesJournal of Infection in Developing Countries, 2007
Neisseria meningitidis is a major cause of invasive bacterial infection in children of all ages. Children less than 1 year of age are at greater risk of invasive disease than older children. In endemic countries, the invasive meningococcal infections are
Victor Perez-Pico,1 Eduardo Llausas-Magana,1 Angel Leon-Ramirez,1 Giordano Perez-Gaxiola,2 and Nidia Leon-Sicairos.3
doaj  

Invasive meningococcal disease without meningitis: a forgotten diagnosis

open access: yes, 2018
Saqib Walayat,1 Nooreen Hussain,1 Abdullah H Malik,1 Elsa Vazquez-Melendez,1 Bhagat S Aulakh,2 Teresa Lynch1 1Department of Internal Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA; 2Department of Pulmonary/Critical Care ...
Walayat S   +5 more
core  

Home - About - Disclaimer - Privacy